Most just lately, it's been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in identical areas as classical opioid receptors, it binds to a wide array of endogenous opioids. Contrary to most opioid receptors, this receptor acts like a scavenger https://neilc420cef1.sharebyblog.com/profile